JPS5838421B2 - 分岐鎖状ケト酸のオルニチン及びアルギニン塩並びに肝臓及び腎臓障害の治療への使用 - Google Patents

分岐鎖状ケト酸のオルニチン及びアルギニン塩並びに肝臓及び腎臓障害の治療への使用

Info

Publication number
JPS5838421B2
JPS5838421B2 JP54030069A JP3006979A JPS5838421B2 JP S5838421 B2 JPS5838421 B2 JP S5838421B2 JP 54030069 A JP54030069 A JP 54030069A JP 3006979 A JP3006979 A JP 3006979A JP S5838421 B2 JPS5838421 B2 JP S5838421B2
Authority
JP
Japan
Prior art keywords
ornithine
arginine
keto
compound according
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54030069A
Other languages
English (en)
Japanese (ja)
Other versions
JPS54163518A (en
Inventor
マケンジー・ワルサー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UIRISU SHII MADORII
Original Assignee
UIRISU SHII MADORII
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UIRISU SHII MADORII filed Critical UIRISU SHII MADORII
Publication of JPS54163518A publication Critical patent/JPS54163518A/ja
Publication of JPS5838421B2 publication Critical patent/JPS5838421B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP54030069A 1978-03-17 1979-03-16 分岐鎖状ケト酸のオルニチン及びアルギニン塩並びに肝臓及び腎臓障害の治療への使用 Expired JPS5838421B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/887,570 US4228099A (en) 1978-03-17 1978-03-17 Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders

Publications (2)

Publication Number Publication Date
JPS54163518A JPS54163518A (en) 1979-12-26
JPS5838421B2 true JPS5838421B2 (ja) 1983-08-23

Family

ID=25391422

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54030069A Expired JPS5838421B2 (ja) 1978-03-17 1979-03-16 分岐鎖状ケト酸のオルニチン及びアルギニン塩並びに肝臓及び腎臓障害の治療への使用

Country Status (17)

Country Link
US (1) US4228099A (OSRAM)
JP (1) JPS5838421B2 (OSRAM)
AU (1) AU517505B2 (OSRAM)
BE (1) BE874900A (OSRAM)
CA (1) CA1115729A (OSRAM)
DE (1) DE2910221A1 (OSRAM)
DK (1) DK153542C (OSRAM)
ES (1) ES478710A1 (OSRAM)
FI (1) FI72118C (OSRAM)
FR (1) FR2419723A1 (OSRAM)
GB (1) GB2017094B (OSRAM)
IE (1) IE48336B1 (OSRAM)
IT (1) IT1202904B (OSRAM)
LU (1) LU81057A1 (OSRAM)
NL (1) NL7902136A (OSRAM)
NO (1) NO151119C (OSRAM)
SE (1) SE446724B (OSRAM)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296127A (en) * 1979-04-18 1981-10-20 The Johns Hopkins University Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof
DE3438455A1 (de) * 1984-10-19 1986-06-26 Institut Dr. Ziegler, Bettingen L-lysin- und l-histidinpyruvat
US4677121A (en) * 1985-01-22 1987-06-30 The Johns Hopkins University Method of inhibiting muscle protein degradation
US4752619A (en) * 1985-12-23 1988-06-21 The Johns Hopkins University Nutritional supplement for treatment of uremia
US4744990A (en) * 1986-09-25 1988-05-17 W. R. Grace & Co. Hydantoins as animal food supplements
US4871552A (en) * 1986-09-25 1989-10-03 W. R. Grace & Co.-Conn. Hydantoins as animal food supplements
US5639731A (en) * 1987-05-22 1997-06-17 Pripps Bryggerier Ab Amino acids for the preparation of a beverage
FR2615734B1 (fr) * 1987-05-27 1989-12-01 Synthelabo Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
AT393079B (de) * 1989-03-06 1991-08-12 Lubec Gert Pharmazeutische verwendung von agmatin
AT393080B (de) * 1988-11-25 1991-08-12 Lubec Gert Pharmazeutische verwendung von arginin (salzen)
SE462463B (sv) * 1988-12-02 1990-07-02 Decken Alexandra V D Livs- och fodermedel innehaallande ketosyror
JP2522034B2 (ja) * 1988-12-27 1996-08-07 味の素株式会社 α−ケト酸・アミノ酸塩化合物及びその製造方法
US5210098A (en) * 1990-09-21 1993-05-11 Regents Of The University Of Minnesota Use of pyruvate to treat acute renal failure
US5234696A (en) * 1991-12-27 1993-08-10 Abbott Laboratories Method of producing tablets, tablets produced thereby, and method of treatment using same
CA2177380A1 (fr) 1994-10-07 1996-04-18 Godefridus Van Den Ouweland Compositions aromatisantes et procede d'aromatisation
US5591736A (en) * 1995-07-03 1997-01-07 The Johns Hopkins University Method of retarding the progression of chronic renal failure
AU2002254525B2 (en) * 2001-04-04 2004-12-23 Critical Therapeutics, Inc. Method for preventing acute renal failure
US7772280B2 (en) * 2004-11-15 2010-08-10 Kyowa Hakko Bio Co., Ltd. Crystals of L-ornithine and process for producing the same
ES2341120T3 (es) * 2004-11-26 2010-06-15 Ucl Business Plc Composiciones que comprenden ornitina y fenilacetato o fenilbutirato para tratar encefalopatia hepatica.
GB0426141D0 (en) * 2004-11-26 2004-12-29 Ucl Biomedica Plc Treatment
EA023051B1 (ru) * 2009-04-03 2016-04-29 Осера Терапьютикс, Инк. Кристаллические формы фенилацетата l-орнитина и их применение
EA025735B1 (ru) 2009-06-08 2017-01-30 ЮСиЭл БИЗНЕС ПиЭлСи Способ лечения портальной гипертензии с использованием l-орнитина в сочетании по меньшей мере с одним из соединений, выбранных из фенилацетата и фенилбутирата
ES2720148T3 (es) 2010-10-06 2019-07-18 Ocera Therapeutics Inc Métodos de fabricación de fenilacetato de L-ornitina
DK3223829T3 (da) 2014-11-24 2020-02-10 Ucl Business Ltd Behandling af sygdomme associeret med hepatisk stellat-celleaktivering under anvendelse af ammoniak-sænkende terapier
EP3337473A4 (en) 2015-08-18 2019-04-17 Ocera Therapeutics, Inc. TREATMENT AND PREVENTION OF MUSCLE WOUND BY L-ORNITHIN IN COMBINATION WITH AT LEAST ONE PHENYL ACETATE AND PHENYL BUTYRATE
CN106674057A (zh) * 2015-11-09 2017-05-17 江西乐维生物药业有限公司 L-精氨酸a-酮基异己酸盐的制备方法
US11219611B2 (en) 2015-11-13 2022-01-11 Ocera Therapeutics, Inc. Formulations of L-ornithine phenylacetate
WO2017090007A1 (en) * 2015-11-29 2017-06-01 Rao M Surya Compositions and methods for the treatment of urea cycle disorders and hepatic diseases
JP7126520B2 (ja) 2017-05-11 2022-08-26 オセラ セラピューティクス， インコーポレイテッド Ｌ－オルニチンフェニルアセテートを製造する方法
WO2019108809A2 (en) 2017-11-29 2019-06-06 Hull Edgar L Jr Alpha keto acid compositions for treating hypo-albuminemia
US12109254B2 (en) 2017-11-29 2024-10-08 Edgar Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
US11484579B2 (en) 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA814483A (en) * 1969-06-03 Abe Kyuji L-ornithine-l-aspartate
GB1034358A (en) 1963-05-01 1966-06-29 Chugai Pharmaceutical Co Ltd Body-protein-biosynthesis promoting composition
FR1432756A (fr) 1965-02-11 1966-03-25 D Opochimiotherapie Lab Pyruvates d'amino-acides et leur procédé de préparation
US3441650A (en) * 1965-07-23 1969-04-29 Lab Jacques Logeais Sa Therapy of ammonical intoxications by di-l-ornithine alpha-ketoglutarate
DE2335215B2 (de) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
US4100161A (en) * 1974-04-15 1978-07-11 The Johns Hopkins University Promotion of protein synthesis and suppression of urea formation in the body by keto analogs of essential amino acids
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same

Also Published As

Publication number Publication date
US4228099A (en) 1980-10-14
IT7921071A0 (it) 1979-03-16
FR2419723B1 (OSRAM) 1982-10-29
LU81057A1 (fr) 1979-09-07
NO151119C (no) 1985-02-13
NL7902136A (nl) 1979-09-19
DK153542B (da) 1988-07-25
AU517505B2 (en) 1981-08-06
DK110879A (da) 1979-09-18
SE7902401L (sv) 1979-10-16
DK153542C (da) 1988-12-05
GB2017094B (en) 1982-07-07
DE2910221C2 (OSRAM) 1988-04-28
FI72118B (fi) 1986-12-31
JPS54163518A (en) 1979-12-26
IE48336B1 (en) 1984-12-12
AU4515479A (en) 1979-09-20
GB2017094A (en) 1979-10-03
CA1115729A (en) 1982-01-05
ES478710A1 (es) 1980-01-16
NO151119B (no) 1984-11-05
NO790903L (no) 1979-09-18
IE790993L (en) 1979-09-17
FI790901A7 (fi) 1979-09-18
BE874900A (fr) 1979-07-16
FR2419723A1 (fr) 1979-10-12
SE446724B (sv) 1986-10-06
DE2910221A1 (de) 1979-09-20
IT1202904B (it) 1989-02-15
FI72118C (fi) 1987-04-13

Similar Documents

Publication Publication Date Title
JPS5838421B2 (ja) 分岐鎖状ケト酸のオルニチン及びアルギニン塩並びに肝臓及び腎臓障害の治療への使用
US4320146A (en) Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids
EP0491708B1 (en) Isolating aminoarginine and use to block nitric oxide formation in body
TWI279230B (en) Pregabalin composition
EP0914315B1 (en) Stable, non-hygroscopic salts of l(-)carnitine and alkanoyl l(-)carnitines, a process for their preparation and solid, orally administrable compositions containing such salts
JPH11506766A (ja) 炎症反応を抑制するためのジ−ベータ−ｄ−グルコピラノシルアミン化合物の使用、及び合成方法
US6054480A (en) Fatty acids as a diet supplement
JPS60120995A (ja) 新規アミノ酸誘導体の製法
PT1409449E (pt) Alfa-cetoglutaratos de componentes activos e composições que os contêm
US20060240120A1 (en) Composition for lowering blood glucose
FI60851C (fi) Foerfarande foer framstaellning av foer urinstensbehandling laempligt aluminiumpolyhydroxisulfat-hydrat
WO2011085701A1 (zh) 稳定的蛋白激酶激活剂及其制备方法和用途
CN118684638A (zh) 一种左旋肉碱维生素c加合物的制备方法及加合物与应用
WO2008115920A2 (en) Methods for the preparation and formulation of l-carnitine valproate salts
JPH06509362A (ja) アルファ−ケトルグルタル酸塩の用法
JPH01268682A (ja) 腎機能改善剤及びリソスペルミン酸塩の製造方法
KR20040010666A (ko) ２ 형 인슐린 내성 당뇨병 환자의 치료를 위한 비오틴과회합된 아세틸 ｌ-카르니틴의 용도
JP2948122B2 (ja) 筋肉タンパク質の形成及び筋肉物質代謝を高めるための医薬品ならびに該医薬品の製法
JPH07504153A (ja) ３−ヒドロキシ−４−ピロンのガリウム錯体の医薬組成物
US7572832B2 (en) Non-hygroscopic L-carnitine salts
JPH0971528A (ja) 抗腫瘍剤
JP2001517227A (ja) Ｌ−カルニチンもしくはアルカノイル−ｌ−カルニチンと２−アミノエタンスルホン酸との非吸湿性塩を含有する経口投与に適した固体状組成物
JP2009084211A (ja) 神経細胞賦活組成物
WO2000000188A2 (en) Synthetically prepared hydroxy citric acid composition for the treatment and/or prophylaxis of overweight and use thereof
RU2313350C1 (ru) Способ повышения растворимости кальция сукцината, кальция малата и кальция цитрата для детских лекарственных форм